Dermata Therapeutics Inc. Gains 32.73%
Thu, Jul 07, 2022 at 08:37 PM
Dermata Therapeutics Inc. (DRMA:NASDAQ) jumped higher at $0.69, representing a gain of 32.7%. On Thu, Jul 07, 2022, DRMA:NASDAQ touched a New 2-Week High of $0.69. The stock got featured on our News Catalysts scanner on Mon, Jun 13, 2022 at 09:25 AM in the 'BIOTECH' category. From Fri, Jun 24, 2022, the stock recorded 75.00% Up Days and 44.44% Green Days
The stock spiked on Thu, Jun 30, 2022 at $1.04 with a volume of 29M+.
About Dermata Therapeutics Inc. (DRMA:NASDAQ)
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
Top 10 Gainers:
- Grove Collaborative Holdings Inc. Class A (GROV:NYSE), 84.25%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Kiromic BioPharma Inc. (KRBP:NASDAQ), 43.46%
- AcelRx Pharmaceuticals, Inc. (ACRX:NASDAQ), 36.2%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 32.73%
- Magenta Therapeutics, Inc. (MGTA:NASDAQ), 29.77%
- Sphere 3D Corp. (ANY:NASDAQ), 29.46%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 27.38%
- Kubient Inc. (KBNT:NASDAQ), 27.04%
- iSpecimen Inc. (ISPC:NASDAQ), 24.89%